Foot Drop Treatment Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

Foot drop, also known as drop foot, is a gait abnormality caused by weakness or paralysis of the dorsiflexor muscles responsible for lifting the front of the foot during walking. The foot itself is a complex structure made up of three main sections, the forefoot, midfoot, and hindfoot, containing numerous bones, joints, ligaments, tendons, muscles, and nerves that work together for locomotion and balance. Treatment options range from non-invasive approaches such as ankle-foot orthoses (AFOs) and functional electrical stimulation to surgical interventions like nerve decompression and tendon transfers.

• •The condition typically results from damage to the peroneal nerve, stroke, multiple sclerosis, spinal cord injury, or muscular disorders
• •Common treatment modalities include custom or prefabricated AFOs, physical therapy, functional electrical stimulation devices, and surgical procedures
• •The market covers all products, services, and technologies used to diagnose, manage, and treat foot drop across healthcare settings

The market's expansion is primarily fueled by the increasing global burden of neurological conditions such as stroke, multiple sclerosis, and cerebral palsy, which are leading causes of foot drop. A growing elderly population, more susceptible to nerve compression injuries like peroneal nerve palsy, further amplifies demand for treatment solutions. Additionally, rising awareness of treatment options, improved access to healthcare in emerging economies, and continuous innovation in orthotic device design are accelerating market growth at a projected 7.52% compound annual growth rate.

• •Stroke remains the single largest driver of foot drop incidence, with approximately 15 million people experiencing stroke globally each year
• •Diabetes-related peripheral neuropathy is expanding the patient pool, particularly in regions with rising diabetes prevalence
• •Technological improvements in lightweight materials, smart orthotics, and minimally invasive surgical techniques are creating new market opportunities

The market is segmented by treatment type, orthotic devices, physical therapy, electrical stimulation, and surgery, as well as by cause of foot drop, including neurological injury, nerve damage, and muscular disorders. Geographically, North America currently leads the market, supported by advanced healthcare infrastructure, favorable reimbursement policies, and high prevalence of underlying neurological conditions. Asia-Pacific is expected to witness the fastest growth due to rising healthcare expenditure, improving medical access, and a large patient population affected by diabetes-related neuropathy and stroke.

• •Orthotic devices, particularly ankle-foot orthoses, represent the largest segment due to their non-invasive nature and broad patient applicability
• •North America holds the dominant market share, with Europe following closely due to aging demographics and strong healthcare systems
• •Asia-Pacific is the fastest-growing region, driven by China and India's large and aging populations, along with increasing diagnosis rates

What are the recent trends and outlook?

Key trends shaping the market include the development of lighter, more customizable AFOs using advanced composite materials, the integration of sensor and Bluetooth technology into functional electrical stimulation devices, and growing adoption of minimally invasive surgical techniques. Ongoing research into regenerative medicine and nerve repair therapies may further diversify treatment options in the coming years. With the market valued at approximately $2.13 billion in 2025 and continuing to expand, the outlook remains positive as innovations improve patient outcomes and expand access to care globally.

• •Wearable technology and smart orthotics with real-time gait analysis and adaptive support are emerging as the next generation of foot drop management
• •Early intervention strategies and improved diagnostic tools are expected to increase treatment adoption rates across all patient demographics
• •The rising burden of neurological diseases and an aging global population will sustain long-term market growth beyond current projections